Comparison of enteral ethanol and benzodiazepines for alcohol withdrawal in neurocritical care patients

Gregory Gipson, Kim Tran, Cuong Hoang, Miriam Treggiari

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We designed a study to evaluate the use of benzodiazepines and ethanol in patients being assessed for alcohol withdrawal and compare outcomes between the two agents. This is a retrospective chart review of patients admitted to neurocritical care or neurosurgical services who were at risk for ethanol withdrawal between June 2011 and September 2015. Patients were divided into two groups based on the first medication administered for alcohol withdrawal management, either benzodiazepine (n = 50) or enteral ethanol (n = 50). The primary endpoint was the maximum change in Clinical Institute Withdrawal Assessment of Alcohol scale (CIWA) score within the first 24. hours. Secondary endpoints included maximum and minimum CIWA score in 5. days, length of stay, and change in Glasgow Coma Scale. Study groups differed by mortality risk, level of coma at admission, and other clinical characteristics, with the ethanol group appearing less severely ill. There was no significant difference between the two groups in the maximum change in CIWA score at 24. hours (-0.97, 95%CI: -3.21 to 1.27, p = 0.39). Hospital and intensive care unit length of stay was 6.5 days and 1 day shorter for the ethanol group (p = 0.03 and p = 0.02, respectively). In summary, enteral ethanol was preferentially used in patients who are more likely to be capable of tolerating oral intake. We found that the change from baseline in CIWA score or other physiologic variables was not substantially different between the two agents. The overall utility of benzodiazepines and enteral ethanol remains unclear for this population and further study is needed to determine superiority.

Original languageEnglish (US)
JournalJournal of Clinical Neuroscience
DOIs
StateAccepted/In press - Nov 24 2015

Fingerprint

Benzodiazepines
Small Intestine
Patient Care
Ethanol
Alcohols
Length of Stay
Glasgow Coma Scale
Coma
Intensive Care Units
Mortality
Population

Keywords

  • Alcohol
  • Benzodiazepine
  • Ethanol
  • Neurocritical care
  • Neurosurgery
  • Withdrawal

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Physiology (medical)

Cite this

Comparison of enteral ethanol and benzodiazepines for alcohol withdrawal in neurocritical care patients. / Gipson, Gregory; Tran, Kim; Hoang, Cuong; Treggiari, Miriam.

In: Journal of Clinical Neuroscience, 24.11.2015.

Research output: Contribution to journalArticle

@article{e4b0e53ecfe14174b1fd542b2095ca9a,
title = "Comparison of enteral ethanol and benzodiazepines for alcohol withdrawal in neurocritical care patients",
abstract = "We designed a study to evaluate the use of benzodiazepines and ethanol in patients being assessed for alcohol withdrawal and compare outcomes between the two agents. This is a retrospective chart review of patients admitted to neurocritical care or neurosurgical services who were at risk for ethanol withdrawal between June 2011 and September 2015. Patients were divided into two groups based on the first medication administered for alcohol withdrawal management, either benzodiazepine (n = 50) or enteral ethanol (n = 50). The primary endpoint was the maximum change in Clinical Institute Withdrawal Assessment of Alcohol scale (CIWA) score within the first 24. hours. Secondary endpoints included maximum and minimum CIWA score in 5. days, length of stay, and change in Glasgow Coma Scale. Study groups differed by mortality risk, level of coma at admission, and other clinical characteristics, with the ethanol group appearing less severely ill. There was no significant difference between the two groups in the maximum change in CIWA score at 24. hours (-0.97, 95{\%}CI: -3.21 to 1.27, p = 0.39). Hospital and intensive care unit length of stay was 6.5 days and 1 day shorter for the ethanol group (p = 0.03 and p = 0.02, respectively). In summary, enteral ethanol was preferentially used in patients who are more likely to be capable of tolerating oral intake. We found that the change from baseline in CIWA score or other physiologic variables was not substantially different between the two agents. The overall utility of benzodiazepines and enteral ethanol remains unclear for this population and further study is needed to determine superiority.",
keywords = "Alcohol, Benzodiazepine, Ethanol, Neurocritical care, Neurosurgery, Withdrawal",
author = "Gregory Gipson and Kim Tran and Cuong Hoang and Miriam Treggiari",
year = "2015",
month = "11",
day = "24",
doi = "10.1016/j.jocn.2016.02.028",
language = "English (US)",
journal = "Journal of Clinical Neuroscience",
issn = "0967-5868",
publisher = "Churchill Livingstone",

}

TY - JOUR

T1 - Comparison of enteral ethanol and benzodiazepines for alcohol withdrawal in neurocritical care patients

AU - Gipson, Gregory

AU - Tran, Kim

AU - Hoang, Cuong

AU - Treggiari, Miriam

PY - 2015/11/24

Y1 - 2015/11/24

N2 - We designed a study to evaluate the use of benzodiazepines and ethanol in patients being assessed for alcohol withdrawal and compare outcomes between the two agents. This is a retrospective chart review of patients admitted to neurocritical care or neurosurgical services who were at risk for ethanol withdrawal between June 2011 and September 2015. Patients were divided into two groups based on the first medication administered for alcohol withdrawal management, either benzodiazepine (n = 50) or enteral ethanol (n = 50). The primary endpoint was the maximum change in Clinical Institute Withdrawal Assessment of Alcohol scale (CIWA) score within the first 24. hours. Secondary endpoints included maximum and minimum CIWA score in 5. days, length of stay, and change in Glasgow Coma Scale. Study groups differed by mortality risk, level of coma at admission, and other clinical characteristics, with the ethanol group appearing less severely ill. There was no significant difference between the two groups in the maximum change in CIWA score at 24. hours (-0.97, 95%CI: -3.21 to 1.27, p = 0.39). Hospital and intensive care unit length of stay was 6.5 days and 1 day shorter for the ethanol group (p = 0.03 and p = 0.02, respectively). In summary, enteral ethanol was preferentially used in patients who are more likely to be capable of tolerating oral intake. We found that the change from baseline in CIWA score or other physiologic variables was not substantially different between the two agents. The overall utility of benzodiazepines and enteral ethanol remains unclear for this population and further study is needed to determine superiority.

AB - We designed a study to evaluate the use of benzodiazepines and ethanol in patients being assessed for alcohol withdrawal and compare outcomes between the two agents. This is a retrospective chart review of patients admitted to neurocritical care or neurosurgical services who were at risk for ethanol withdrawal between June 2011 and September 2015. Patients were divided into two groups based on the first medication administered for alcohol withdrawal management, either benzodiazepine (n = 50) or enteral ethanol (n = 50). The primary endpoint was the maximum change in Clinical Institute Withdrawal Assessment of Alcohol scale (CIWA) score within the first 24. hours. Secondary endpoints included maximum and minimum CIWA score in 5. days, length of stay, and change in Glasgow Coma Scale. Study groups differed by mortality risk, level of coma at admission, and other clinical characteristics, with the ethanol group appearing less severely ill. There was no significant difference between the two groups in the maximum change in CIWA score at 24. hours (-0.97, 95%CI: -3.21 to 1.27, p = 0.39). Hospital and intensive care unit length of stay was 6.5 days and 1 day shorter for the ethanol group (p = 0.03 and p = 0.02, respectively). In summary, enteral ethanol was preferentially used in patients who are more likely to be capable of tolerating oral intake. We found that the change from baseline in CIWA score or other physiologic variables was not substantially different between the two agents. The overall utility of benzodiazepines and enteral ethanol remains unclear for this population and further study is needed to determine superiority.

KW - Alcohol

KW - Benzodiazepine

KW - Ethanol

KW - Neurocritical care

KW - Neurosurgery

KW - Withdrawal

UR - http://www.scopus.com/inward/record.url?scp=84973904616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973904616&partnerID=8YFLogxK

U2 - 10.1016/j.jocn.2016.02.028

DO - 10.1016/j.jocn.2016.02.028

M3 - Article

JO - Journal of Clinical Neuroscience

JF - Journal of Clinical Neuroscience

SN - 0967-5868

ER -